Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. [electronic resource]
Producer: 20151116Description: 6149-58 p. digitalISSN:- 1423-0380
- Animals
- Apoptosis -- drug effects
- Astemizole -- administration & dosage
- Biomarkers, Tumor -- biosynthesis
- Carcinoma, Hepatocellular -- drug therapy
- Cell Proliferation -- drug effects
- Diethylnitrosamine -- administration & dosage
- Ether-A-Go-Go Potassium Channels -- biosynthesis
- Gene Expression Regulation, Neoplastic
- Hep G2 Cells
- Humans
- Liver Neoplasms -- drug therapy
- Neoplasm Staging
- Prognosis
- Rats
- gamma-Glutamyltransferase -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.